Historical record - last NADAC publication: 8/23/2023

Product Information

PIOGLITAZONE HCL 45 MG TABLET is a generic product labeled by Solco Healthcare US LLC, priced at $0.1370 per EA under NDC 43547042850. Its NADAC has been published 218 times since Jun 26, 2019.

The High Outlier badge above means this manufacturer's average price in the Pioglitazone market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

PIOGLITAZONE HCL 45 MG TABLET

Pioglitazone
$0.1370per EA
High Outlier

Strength

45 mg/1

NDC

43547042850

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

8/23/2023

Active Ingredients

PIOGLITAZONE

Approval Type

Generic (ANDA)

FDA Application

ANDA207806

On Market Since

5/20/2018

Pharmacological Classes

PPAR alpha
PPAR gamma
Peroxisome Proliferator Receptor alpha Agonist
Peroxisome Proliferator Receptor gamma Agonist
Peroxisome Proliferator-activated Receptor Activity
Thiazolidinedione
Thiazolidinediones

Price Statistics

The NADAC for PIOGLITAZONE HCL 45 MG TABLET has been published 218 times since Jun 26, 2019, and over the history we have for it it has declined 3.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1370 per EA
All-time high$0.1794 (Jan 13, 2021)
All-time low$0.1281 (Aug 21, 2019)
Median price$0.1465
Average price$0.1519
Largest weekly change+13.5% (Jun 17, 2020)
Weeks tracked218
Tracking sinceJun 26, 2019

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

-6.5%

5Y

-17.4%

All

-3.1%

Generic Alternatives

The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 16% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of PIOGLITAZONE HCL 45 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PIOGLITAZONE HCL 45 MG TABLET, manufactured by Solco Healthcare US LLC, is $0.1370 per EA (NDC 43547042850), effective Aug 23, 2023.

How has the price of PIOGLITAZONE HCL 45 MG TABLET changed over time?

Over the history we have for it, the NADAC for PIOGLITAZONE HCL 45 MG TABLET has declined 3.1%. It has been tracked across 218 weekly CMS publications since Jun 26, 2019.

What are the highest and lowest recorded NADAC prices for PIOGLITAZONE HCL 45 MG TABLET?

Since Jun 26, 2019, the NADAC for PIOGLITAZONE HCL 45 MG TABLET has ranged from a low of $0.1281 (Aug 21, 2019) to a high of $0.1794 (Jan 13, 2021), with a median of $0.1465 per EA.

Are there cheaper alternatives to PIOGLITAZONE HCL 45 MG TABLET?

Yes. 5 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, PIOGLITAZONE HCL 45 MG TABLET, is $0.1144 per EA — about 16% below PIOGLITAZONE HCL 45 MG TABLET.

Who manufactures PIOGLITAZONE HCL 45 MG TABLET?

PIOGLITAZONE HCL 45 MG TABLET (NDC 43547042850) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.